This inventor holds 2 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1990-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-2006
Title: Ellen G McMahon: Innovator in Cardiac Treatment
Introduction
Ellen G McMahon is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of cardiac treatment, holding 2 patents that focus on innovative therapeutic methods.
Latest Patents
Her latest patents include a method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone. This therapeutic method is designed for treating cardiofibrosis or cardiac hypertrophy using a combination therapy comprising a therapeutically-effective amount of an angiotensin II receptor antagonist and a therapeutically-effective amount of epoxymexrenone. Additionally, she has developed a class of 8-azapurin-6-one derivatives for the control of hypertension, with a particular focus on the compound 8-aza-2-(2-n-propoxyphenyl)purin-6-one.
Career Highlights
Ellen G McMahon has worked at G.D. Searle & Company, where she has been able to apply her innovative ideas in a professional setting. Her work has contributed to advancements in medical treatments, particularly in cardiology.
Collaborations
She has collaborated with notable coworkers such as Gillian M Olins and Robert E Manning, further enhancing her research and development efforts.
Conclusion
Ellen G McMahon's contributions to cardiac treatment through her patents demonstrate her commitment to innovation in the medical field. Her work continues to impact the lives of many individuals suffering from cardiac conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile